Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Peter B. Ward"'
Autor:
Stefano Giulieri, Ashleigh S Hayes, Ian R. Monk, Sarah L. Baines, Romain Guérillot, Natasha E Holmes, Diane Daniel, Torsten Seemann, Timothy P. Stinear, Wei Gao, Jason C Kwong, Norelle L Sherry, Benjamin P Howden, Peter B. Ward
Publikováno v:
mBio, Vol 11, Iss 6 (2020)
mBio
mBio
The majority of Staphylococcus aureus strains causing human disease are methicillin-susceptible (MSSA) and can be treated with antistaphylococcal penicillins (such as oxacillin). While acquisition of the mec gene represents the main resistance mechan
Publikováno v:
Pathology. 50:584-587
Publikováno v:
Journal of Medical Microbiology. 62:1350-1356
In this study, a total of 650 stool samples were tested to show that our method is capable of detecting four Clostridium difficile genes; tcdA, tcdB, encoding toxin A (TcdA) and toxin B (TcdB), and the binary toxin C. difficile transferase genes (cdt
Autor:
Asha C. Bowen, Jonathan R. Carapetis, Robert W. Baird, Rachael A. Lilliebridge, Malcolm McDonald, Steven Y. C. Tong, Bart J. Currie, Peter B. Ward
Publikováno v:
Journal of Clinical Microbiology. 50:4067-4072
Streptococcus pyogenes is commonly believed to be resistant to trimethoprim-sulfamethoxazole (SXT), resulting in reservations about using SXT for skin and soft tissue infections (SSTI) where S. pyogenes is involved. S. pyogenes ' in vitro susceptibil
Publikováno v:
Journal of Clinical Microbiology. 46:1961-1964
We have isolated a number of vanB -containing Enterococcus faecium isolates on bile esculin screening agar containing 6 mg/liter vancomycin, which on subsequent susceptibility testing using Etest have repeatedly demonstrated vancomycin MICs of ≤4 m
Publikováno v:
The Journal of hospital infection. 90(4)
Summary Background Alkane vapocoolant sprays evaporate rapidly, lower skin temperature and result in a temporary interruption in pain sensation. They reduce the pain of intravenous cannulation. However, concern exists that they may recontaminate the
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:3039-3047
Low-level vancomycin-resistant Staphylococcus aureus (vancomycin-intermediate S. aureus [VISA] and heterogenous VISA [hVISA]) is increasingly reported and leads to glycopeptide treatment failure. Various phenotypic features have been reported for the
Publikováno v:
Clinical Infectious Diseases. 38:448-451
We assessed all episodes of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at our hospital during a 12-month period (n=53) and compared those due to heterogeneous vancomycin-intermediate S. aureus (hVISA; n = 5, 9.4%) with those due to
Autor:
Peter B. Ward, Susan A Ballard, E. A. Grabsch, M. L. Grayson, Paul D R Johnson, Wei Gao, S. Khumra
Publikováno v:
Infection Control & Hospital Epidemiology. 33:98-100
Autor:
Vicki Bennett-Wood, David J. Hampson, Roy M. Robins-Browne, Andrew Mikosza, Peter B. Ward, Ralf G. Heine
Publikováno v:
Journal of Gastroenterology and Hepatology. 16:872-875
Aim: The clinical presentation of four children and adolescents (two males and two females with a mean age of 12.4 years; range 9-16 years) with colorectal spirochetosis is discussed. Results: Symptoms included persistent diarrhea (n = 2), rectal ble